NEO212

· Neonc Technologies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NEO212, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis [Phase 1, Phase 2]

See pricing